Supernova Bio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
Supernova Bio General Information
Description
Developer of a nano-level production technology designed to image, diagnose, and cure diseases. The company's technology provides novel therapeutics for lipolysis, anti-lipoma, and liposarcoma, enabling patients to overcome these diseases with its treatment.
Contact Information
Website
supernovabio.comCorporate Office
- 103-1302, 67, Seobinggo-ro
- Yongsan-gu
- Seoul, 04385
- South Korea
Corporate Office
- 103-1302, 67, Seobinggo-ro
- Yongsan-gu
- Seoul, 04385
- South Korea
Supernova Bio Timeline
Supernova Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 16-Apr-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 03-Jul-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Sep-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Supernova Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Supernova Bio Patents
Supernova Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3203170-A1 | Fatty acid- modified polymer nanoparticles, and use thereof | Pending | 24-Dec-2020 | ||
| JP-7768587-B2 | Fatty acid-incorporated polymeric nanoparticles and their uses | Active | 24-Dec-2020 | ||
| JP-2024500500-A | Fatty acid-introduced polymer nanoparticles and their uses | Active | 24-Dec-2020 | ||
| AU-2021409688-A1 | Fatty acid-modified polymer nanoparticles, and use thereof | Active | 24-Dec-2020 | ||
| AU-2021409688-A9 | Fatty acid-modified polymer nanoparticles, and use thereof | Active | 24-Dec-2020 |
Supernova Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Supernova Bio Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innocube | Accelerator/Incubator | Minority | ||
| CreactiveHealth+ | VC-Backed Company | Minority | ||
| Hanyang University Technology Holdings | Venture Capital | Minority |
Supernova Bio FAQs
-
When was Supernova Bio founded?
Supernova Bio was founded in 2018.
-
Where is Supernova Bio headquartered?
Supernova Bio is headquartered in Seoul, South Korea.
-
What is the size of Supernova Bio?
Supernova Bio has 3 total employees.
-
What industry is Supernova Bio in?
Supernova Bio’s primary industry is Drug Discovery.
-
Is Supernova Bio a private or public company?
Supernova Bio is a Private company.
-
What is Supernova Bio’s current revenue?
The current revenue for Supernova Bio is .
-
How much funding has Supernova Bio raised over time?
Supernova Bio has raised $231K.
-
Who are Supernova Bio’s investors?
Innocube, CreactiveHealth+, and Hanyang University Technology Holdings have invested in Supernova Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
